Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases

Background. Histoplasmosis may complicate tumor necrosis factor (TNF)–α blocker therapy. Published case series provide limited guidance on disease management. We sought to determine the need for long-term antifungal therapy and the safety of resuming TNF-α blocker therapy after successful treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: Vergidis, Paschalis, Avery, Robin K., Wheat, L. Joseph, Dotson, Jennifer L., Assi, Maha A., Antoun, Smyrna A., Hamoud, Kassem A., Burdette, Steven D., Freifeld, Alison G., McKinsey, David S., Money, Mary E., Myint, Thein, Andes, David R., Hoey, Cynthia A., Kaul, Daniel A., Dickter, Jana K., Liebers, David E., Miller, Rachel A., Muth, William E., Prakash, Vidhya, Steiner, Frederick T., Walker, Randall C., Hage, Chadi A.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Articles and Commentaries
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4796723/
https://ncbi.nlm.nih.gov/pubmed/25870331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ299
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares